Osimertinib related cardiotoxicity in patients with non-small cell lung cancer

被引：0
|
作者：
Mensah, Samuel Akaakole [1 ]
Alruwaili, Waleed [1 ]
Ahmad, Syed [1 ]
Patel, Brijesh [1 ]
Almubarak, Mohammed [1 ]
机构：
[1] West Virginia Univ, Morgantown, WV 26506 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20011
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Safety of osimertinib in EGFR-mutated non-small cell lung cancer
    Mezquita, Laura
    Varga, Andreea
    Planchard, David
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (12) : 1239 - 1248
  • [32] Incidence of Cardiotoxicity in Patients Treated for Non-Small Cell Lung Cancer with Immune Checkpoint Inhibitors
    Carpenter, I. N.
    Brice, K. B.
    Walker, D.
    Dumais, K.
    Alvarez, A. M.
    Cohen, N. S.
    Raez, L. E.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S629 - S629
  • [33] Cardiotoxicity of cisplatin-based chemotherapy in advanced non-small cell lung cancer patients
    Demkow, Urszula
    Stelmaszczyk-Emmel, Anna
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2013, 187 (01) : 64 - 67
  • [34] ASSESSING THE UTILIZATION OF DIABETIC NON-SMALL CELL LUNG CANCER PATIENTS COMPARED TO NON-SMALL CELL LUNG CANCER PATIENTS
    Ruban, C.
    Blanchette, C. M.
    Howden, R.
    Kowalkowski, M.
    Marino, J.
    Saunders, W.
    VALUE IN HEALTH, 2017, 20 (09) : A511 - A511
  • [35] Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer
    van Veggel, B.
    Santos, J. F. Vilacha Madeira R.
    Hashemi, S. M. S.
    Paats, M. S.
    Monkhorst, K.
    Heideman, D. A. M.
    Groves, M.
    Radonic, T.
    Smit, E. F.
    Schuuring, E.
    van der Wekken, A. J.
    de Langen, A. J.
    LUNG CANCER, 2020, 141 : 9 - 13
  • [36] Relationship Between Osimertinib Concentration and Clinical Response in Japanese Patients With Non-small Cell Lung Cancer
    Yamazaki, Mizuki
    Komizo, Nao
    Iihara, Hirotoshi
    Hirose, Chiemi
    Yanase, Komei
    Yamada, Yuto
    Endo, Junki
    Yamashita, Shuji
    Ohno, Yasushi
    Todoroki, Kenichiro
    Suzuki, Akio
    Hayashi, Hideki
    ANTICANCER RESEARCH, 2023, 43 (02) : 725 - 732
  • [37] Efficacy of Osimertinib in Patients of Advanced Non-Small Cell Lung Cancer with Brain Metastasis: A Retrospective Analysis
    Zhang, J.
    Chen, L.
    Ye, M.
    Li, H.
    Zhou, C.
    Pan, H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S911 - S912
  • [38] Osimertinib in Patients With Non-Small Cell Lung Cancer and Uncommon EGFR Mutations-Chasing Unicorns?
    Wang, Victoria E.
    Gainor, Justin F.
    JAMA ONCOLOGY, 2024, 10 (01) : 52 - 53
  • [39] Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance
    Fu, Kai
    Xie, Fachao
    Wang, Fang
    Fu, Liwu
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [40] Weight loss in patients on osimertinib for metastatic EGFR-mutant non-small cell lung cancer
    Chen, Lanyi Nora
    Ma, Xin
    Herzberg, Benjamin
    Henick, Brian S.
    Biswas, Anup K.
    Acharyya, Swarnali
    Shu, Catherine A.
    ONCOLOGIST, 2024,
12345